Literature DB >> 8118964

Implant failure and the immuno-incompetent fibro-inflammatory zone.

A G Gristina1.   

Abstract

Biomaterial implants are surrounded by an immuno-incompetent, fibro-inflammatory, integration-deficient zone within which stimulation of cellular immune responses results in superoxide radical and cytokine-mediated tissue damage with increased susceptibility to infection or aseptic loosening. Three important questions that pertain to surgical implants are (1) What are the mechanisms that cause abnormal inflammatory responses in the absence of infection and result in interface cellular disorganization and device failure? (2) What causes host defenses to be compromised to the extent that normal flora organisms like Staphylococcus epidermidis, with little or no virulence potential, can cause life-threatening infections at the implant-host interface? (3) What is the nature of surface regions of biomaterials that facilitate bacterial adherence? Pathogenic strains of S. epidermidis and Staphylococcus aureus have an affinity for biomaterial surfaces and are capable of initiating infection. Binding may be nonspecific and glue-like rather than a receptor-ligand event as for S. aureus and matrix proteins. This study indicates bacterial binding to sites of higher vanadium concentration at grain boundaries and mixed phases in titanium alloys. Repeated macrophage priming by biomaterial particulates results in the production of reactive oxygen intermediates, macrophage exhaustion, and adjacent tissue damage. A cytokine cascade is also initiated. A self-perpetuating enlarging immuno-incompetent fibro-inflammatory zone develops about implants, which features tissue cell damage, increased susceptibility to infection, and results in septic or aseptic failure of the implant. These effects are clearly exemplified by fibrosis about breast implants and osteolysis at the interface of total joint replacements.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8118964

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


  37 in total

1.  Quantifying subtle but persistent peri-spine inflammation in vivo to submicron cobalt-chromium alloy particles.

Authors:  Nadim James Hallab; Frank W Chan; Megan L Harper
Journal:  Eur Spine J       Date:  2012-03-10       Impact factor: 3.134

2.  Experimental study of a porous rat tracheal prosthesis made of T40: long-term survival analysis.

Authors:  P Schultz; D Vautier; C Egles; C Debry
Journal:  Eur Arch Otorhinolaryngol       Date:  2003-12-04       Impact factor: 2.503

3.  Biodegradable drug delivery system for the treatment of bone infection and repair.

Authors:  L Di Silvio; W Bonfield
Journal:  J Mater Sci Mater Med       Date:  1999 Oct-Nov       Impact factor: 3.896

4.  An extended spectrum bactericidal titanium dioxide (TiO2) coating for metallic implants: in vitro effectiveness against MRSA and mechanical properties.

Authors:  Maximilian Haenle; Andreas Fritsche; Carmen Zietz; Rainer Bader; Frank Heidenau; Wolfram Mittelmeier; Hans Gollwitzer
Journal:  J Mater Sci Mater Med       Date:  2010-12-29       Impact factor: 3.896

Review 5.  [Treatment of infected total knee arthroplasty. When does implant salvage make sense?].

Authors:  T Kern; H Gollwitzer; M Militz; V Bühren
Journal:  Orthopade       Date:  2006-09       Impact factor: 1.087

6.  An entropic perspective of protein stability on surfaces.

Authors:  Thomas A Knotts; Nitin Rathore; Juan J de Pablo
Journal:  Biophys J       Date:  2008-03-07       Impact factor: 4.033

7.  Assessment of epidural versus intradiscal biocompatibility of PEEK implant debris: an in vivo rabbit model.

Authors:  Nadim J Hallab; Qi-Bin Bao; Tim Brown
Journal:  Eur Spine J       Date:  2013-08-31       Impact factor: 3.134

Review 8.  [Classification of prosthetic loosening and determination of wear particles].

Authors:  M Otto
Journal:  Pathologe       Date:  2008-11       Impact factor: 1.011

9.  The Scar-in-a-Jar: studying potential antifibrotic compounds from the epigenetic to extracellular level in a single well.

Authors:  C Z C Chen; Y X Peng; Z B Wang; P V Fish; J L Kaar; R R Koepsel; A J Russell; R R Lareu; M Raghunath
Journal:  Br J Pharmacol       Date:  2009-09-28       Impact factor: 8.739

10.  Focus on collagen: in vitro systems to study fibrogenesis and antifibrosis state of the art.

Authors:  Clarice Zc Chen; Michael Raghunath
Journal:  Fibrogenesis Tissue Repair       Date:  2009-12-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.